| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/02/2002 | WO2002034928A1 Non-human transgenic animal expressing ca-ahr |
| 05/02/2002 | WO2002034927A2 Plant genes that confer resistance to strains of magnaporthe grisea having avr1 co39 cultivar specificity gene |
| 05/02/2002 | WO2002034923A2 Monocotyledon plant cells and plants which synthesise modified starch |
| 05/02/2002 | WO2002034918A2 E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereof |
| 05/02/2002 | WO2002034917A2 Secreted alpha-helical cytokine-like protein zlmda24 |
| 05/02/2002 | WO2002034916A2 Novel mutant igbp-3 molecules that do not bind to igfs, but retain their ability to functionally bind igfbp-3 receptor |
| 05/02/2002 | WO2002034915A2 Preferred segments of neural thread protein and methods of using the same |
| 05/02/2002 | WO2002034914A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 05/02/2002 | WO2002034913A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 05/02/2002 | WO2002034912A1 Genomes participating in rheumatoid arthritis, method of the diagnosis thereof, method of evaluating the onset possibility thereof, diagnostic kit for detecting them and therapeutic method and remedies for rheumatoid arthritis |
| 05/02/2002 | WO2002034911A1 Mfq-114, a human ajuba like protein |
| 05/02/2002 | WO2002034910A2 Method for modulating granzyme b uptake and for identifying modulators thereof |
| 05/02/2002 | WO2002034909A2 Engineered chimera of hiv protein fragments and uses thereof |
| 05/02/2002 | WO2002034906A2 Method for exposing peptides and polypeptides on the cell surface of bacteria |
| 05/02/2002 | WO2002034904A1 Novel g protein-coupled receptor protein and dna thereof |
| 05/02/2002 | WO2002034903A2 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications |
| 05/02/2002 | WO2002034894A2 Plant promoter providing high levels of gene expression in fruits |
| 05/02/2002 | WO2002034891A2 Immortalized preosteoblasts and method for their production |
| 05/02/2002 | WO2002034885A1 Sericin-containing material, process for producing the same and method of using the same |
| 05/02/2002 | WO2002034882A2 Genes regulating programmed cell death |
| 05/02/2002 | WO2002034880A2 Cadherin peptides for drug delivery and inhibition of tumor metastasis/invasion |
| 05/02/2002 | WO2002034878A2 Amyloid precursor protein and app-derived peptides inhibit tumor growth and metastasis |
| 05/02/2002 | WO2002034876A2 Protein data analysis |
| 05/02/2002 | WO2002034791A2 Methods of purification and recovery of interferon-beta |
| 05/02/2002 | WO2002034789A1 Monoclonal antibodies directed against hepatitis b viruses |
| 05/02/2002 | WO2002034788A1 Monoclonal antibodies to the map protein and method of use in treating or preventing infections |
| 05/02/2002 | WO2002034787A1 Method of producing human serum albumin involving heating step |
| 05/02/2002 | WO2002034786A1 Method of eliminating human serum albumin polymers |
| 05/02/2002 | WO2002034785A1 Method of monomerizing human serum albumin polymers |
| 05/02/2002 | WO2002034783A2 Transmembrane proteins |
| 05/02/2002 | WO2002034782A2 Endozepine-like polypeptide nov1 and nucleic acid encoding the same |
| 05/02/2002 | WO2002034781A1 Human g-protein coupled diadenosine tetraphosphate receptor (ap4ar) |
| 05/02/2002 | WO2002034780A2 Hetero-oligomeric compounds derived from the tnf cytokine superfamily and their use |
| 05/02/2002 | WO2002034778A2 Baseb209 polypeptides and polynucleotides from haemophilus influenzae |
| 05/02/2002 | WO2002034777A1 Fusion proteins as immunization treatments of alzheimer's disease |
| 05/02/2002 | WO2002034776A2 Epitopes of pai-1 |
| 05/02/2002 | WO2002034774A2 Bacillus thuringiensis proteins and variants thereof with pesticidal activity against coleopterans |
| 05/02/2002 | WO2002034773A2 Streptococcal genes |
| 05/02/2002 | WO2002034772A2 Novel compounds |
| 05/02/2002 | WO2002034771A2 Nucleic acids and proteins from streptococcus groups a & b |
| 05/02/2002 | WO2002034770A1 Identification of hla-dr restricted hcv epitopes |
| 05/02/2002 | WO2002034769A2 Immunoreactive peptide ctl epitopes of human cytomegalovirus pp150 |
| 05/02/2002 | WO2002034768A2 Polypeptides and polynucleodides from haemophilus influenzae and their use |
| 05/02/2002 | WO2002034767A1 Vegf peptides and their use for inhibiting angiogenesis |
| 05/02/2002 | WO2002034766A2 Peptides derived from the human amyloid precursor protein used to protect cells from iron catalyzed oxidative damage |
| 05/02/2002 | WO2002034764A1 A process of producing polyphenolic adhesive proteins and proteins produced in accordance with the process |
| 05/02/2002 | WO2002034312A1 Hydrophobic multicomponent heparin conjugates, a preparing method and a use thereof |
| 05/02/2002 | WO2002034291A2 Compositions and methods for treating hematologic malignancies and multiple drug resistance |
| 05/02/2002 | WO2002034280A2 Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with pain |
| 05/02/2002 | WO2002034205A2 Using heat shock proteins to increase immune response |
| 05/02/2002 | WO2002034202A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 05/02/2002 | WO2002034042A2 Knockout mice thyroid stimulating hormone receptor (tsh-r) gene |
| 05/02/2002 | WO2002034041A1 Senescence marker protein 30-defective nonhuman animal, antibody and method of constructing the same |
| 05/02/2002 | WO2002034034A1 Transgenic plants with reduced expression of endogenous phytochrome a, exhibiting improved rooting, and methods for their production |
| 05/02/2002 | WO2002022080A3 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 05/02/2002 | WO2002020613A3 Process for the purification of epi-hne proteins |
| 05/02/2002 | WO2002019812A3 Mutant non-human mammal for expressing the alpha6 acetylcholine nicotinic receptor subunit and use for screening substances capable of interacting with said receptor |
| 05/02/2002 | WO2002018446A3 Methods of designing and producing compounds having improved binding affinity for cd154 or other trimeric proteins |
| 05/02/2002 | WO2002016399A3 Haplotypes of the tacr1 gene |
| 05/02/2002 | WO2002012537A3 Mutant trichosanthin |
| 05/02/2002 | WO2002010344A3 Synchronised arabidopsis cell suspensions and uses thereof |
| 05/02/2002 | WO2002010206A3 Nucleotide sequences which code for the metf gene |
| 05/02/2002 | WO2002010190A3 Haplotypes of the il12b gene |
| 05/02/2002 | WO2002008253A3 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY |
| 05/02/2002 | WO2002006460A3 Masp-2, a complement-fixing enzyme, and uses for it |
| 05/02/2002 | WO2002004523A3 Artificial antibody polypeptides |
| 05/02/2002 | WO2002003060A3 Process for the measurement of dinophysistoxin and of yessotoxin |
| 05/02/2002 | WO2002002636A3 Membrane associated protein zupari |
| 05/02/2002 | WO2002000831A3 A novel polypeptide, a bromine group domain 12 and the polynucleotide encoding the polypeptide |
| 05/02/2002 | WO2002000829A3 A novel peptide--- human ftsh protein 16.83 and the polynucleotide coding this novel peptide |
| 05/02/2002 | WO2002000825A3 A novel polypeptide, a nuclear receptor protein stromal antigene 110.34 and the polynucleotide encoding the polypeptide |
| 05/02/2002 | WO2002000822A3 A NOVEL POLYPEPTIDE, A HUMAIN PROTEIN SYNTHESIS INITIATION FACTOR SUB-UNIT 2 β 16.5 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE |
| 05/02/2002 | WO2002000686A3 Bioelastomer nanomachines and biosensors |
| 05/02/2002 | WO2001098330A3 A RECOMBINANT CELL LINE EXPRESSING GPCRx11 AS A FUNCTIONAL RECEPTOR VALIDATED BY ANGIOPEPTIN AND USEFUL FOR SCREENING OF AGONISTS AND ANTAGONISTS |
| 05/02/2002 | WO2001097785A3 Basic copolymers for the treatment of prion-related-disease |
| 05/02/2002 | WO2001096527A3 Peptides with physiological activity |
| 05/02/2002 | WO2001096524A3 A novel polypeptide, a human sigma receptor 10.67 and the polynucleotide encoding the polypeptide |
| 05/02/2002 | WO2001096397A3 Cd154 variants and uses thereof |
| 05/02/2002 | WO2001096368A3 Use of coiled-coil structural scaffold to generate structure-specific peptides |
| 05/02/2002 | WO2001094601A3 Hero resistance gene conferring resistance to nematodes |
| 05/02/2002 | WO2001092311A3 Convergent combinatory peptide libraries and their use for vaccination against hepatitis c virus |
| 05/02/2002 | WO2001092301A3 Placc, a novel human c-c chemokine isolated from placenta |
| 05/02/2002 | WO2001090147A3 Long wavelength engineered fluorescent proteins |
| 05/02/2002 | WO2001090141A3 Gb1c isoform and nucleotides |
| 05/02/2002 | WO2001089450A3 Treating musculoskeletal disorders using lp85 and analogs thereof |
| 05/02/2002 | WO2001087932A3 Seven transmembrane proteins and polynucleotides encoding the same |
| 05/02/2002 | WO2001083770A3 Lipolytic enzyme variant |
| 05/02/2002 | WO2001083555A3 Pain signaling molecules |
| 05/02/2002 | WO2001081582A3 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same |
| 05/02/2002 | WO2001079342A3 Cross-linked collagen matrices and methods for their preparation |
| 05/02/2002 | WO2001077137A9 Albumin fusion proteins |
| 05/02/2002 | WO2001074900A3 Nuclear factor kb inducing factor |
| 05/02/2002 | WO2001072778A3 Method of identifying inhibitors of tie-2 |
| 05/02/2002 | WO2001070951A3 Agent for the diagnosis and therapy of viral diseases |
| 05/02/2002 | WO2001070771A3 Acute neuronal induced calcium binding protein type 1 ligand |
| 05/02/2002 | WO2001068824A3 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| 05/02/2002 | WO2001064882A3 1983, 52881, 2398, 45449, 50289, and 52872, g protein-coupled receptors and uses therefor |
| 05/02/2002 | WO2001064875A3 Human transporter genes and proteins encoded thereby |
| 05/02/2002 | WO2001064873A3 Human gtpase activator proteins |
| 05/02/2002 | WO2001064749A3 Method for preparing anti-mif antibodies |